Blown-out myotomy (BOM) is a structural complication that can occur after a previous myotomy for achalasia, a condition where the esophagus has difficulty moving food into the stomach. In BOM, the original myotomy (a surgical cut in the esophageal muscles to improve swallowing) fails or disrupts, leading to poor esophageal emptying and a recurrence of symptoms like difficulty swallowing, chest pain, or regurgitation.
Blown-out myotomy (BOM) is a structural complication that can occur after a previous myotomy for achalasia, a condition where the esophagus has difficulty moving food into the stomach. In BOM, the original myotomy (a surgical cut in the esophageal muscles to improve swallowing) fails or disrupts, leading to poor esophageal emptying and a recurrence of symptoms like difficulty swallowing, chest pain, or regurgitation. When these symptoms significantly impact a patient’s quality of life, it is referred to as symptomatic blown-out myotomy.
Peroral Endoscopic Myotomy (POEM) is a minimally invasive endoscopic procedure that is used as a salvage treatment for symptomatic BOM. During POEM, a flexible endoscope is inserted through the mouth to access the esophagus. The surgeon creates a tunnel in the esophageal lining and cuts the problematic muscle layers to restore proper esophageal function.
The study found that POEM is both safe and effective for treating symptomatic BOM. It had a low rate of complications, even in anatomically altered cases like BOM. Clinical success was high (85.7% at 2 years), meaning most patients experienced significant symptom relief. This makes POEM a reliable option for patients with recurrent achalasia symptoms due to BOM, helping them regain better swallowing and quality of life.
Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...
Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...
Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...
Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...
Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...
Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...
We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.